227 related articles for article (PubMed ID: 16343175)
1. Radical hysterectomy for stage IIB cervical cancer: a review.
Suprasert P; Srisomboon J; Kasamatsu T
Int J Gynecol Cancer; 2005; 15(6):995-1001. PubMed ID: 16343175
[TBL] [Abstract][Full Text] [Related]
2. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
[TBL] [Abstract][Full Text] [Related]
3. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
5. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
6. [Wertheim-Meigs radical hysterectomy for cervical cancer stage IIB].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(2):22-4. PubMed ID: 17469447
[TBL] [Abstract][Full Text] [Related]
7. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
10. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.
Inoue T; Okumura M
Cancer; 1984 Oct; 54(8):1714-9. PubMed ID: 6478409
[TBL] [Abstract][Full Text] [Related]
12. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
13. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
15. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB.
Inoue T; Morita K
Cancer; 1990 May; 65(9):1923-7. PubMed ID: 2372764
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
Yoneda JY; Braganca JF; Sarian LO; Borba PP; Conceição JC; Zeferino LC
Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
[TBL] [Abstract][Full Text] [Related]
20. Postoperative extended-field irradiation in patients with pelvic and/or common iliac node metastases from cervical carcinoma stages IB to IIB.
Inoue T; Chihara T; Morita K
Gynecol Oncol; 1986 Oct; 25(2):234-43. PubMed ID: 3019844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]